Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
LVMC Holdings in Laos chose the Korean bio company as a partner to advance into the pharmaceutical industry
By Jan 26, 2023 (Gmt+09:00)
1
Min read
Most Read
Macquarie eyes its 1st Korean data center valued around $722 mn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![DongKoo Bio CEO Cho Yong-joon and LVMC Holdings CEO Oh Se-young (front row, from left)](https://www.kedglobal.com/data/ked/image/2023/01/26/ked202301260037.620x.0.jpg)
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, the largest private company in Laos. Analysts commented that it is a sign of CEO Cho Yong-joon, the second-generation owner, kicking off his own style of management.
The South Korean company said on Thursday that it recently signed a memorandum of understanding (MOU) with LVMC Holdings to undertake a project to nurture leading companies in the pharmaceutical industry. Earlier on Jan. 17, Mr. Cho had visited Laos with six working-level managers to discuss ways to establish a Korean-made generic drug manufacturing plant.
LVMC Holdings is a company that manufactures and sells automobiles and motorcycles in Vietnam, Myanmar, and Cambodia, in addition to Laos. It has not yet entered the healthcare sector. The Lao company has chosen DongKoo Bio as a partner to advance into the pharmaceutical area.
DongKoo plans to speed up its entry into the healthcare market of 10 ASEAN countries, starting with a drug production plant in Laos. It expects that there will be business opportunities in various fields such as functional health foods, cosmetics, and medical devices.
"To take on the global contract manufacturing organization (CMO) market, we moved into a healthcare market in one of the 10 ASEAN countries. We will make full use of the strengths of the two companies to become a total healthcare leader covering prevention, diagnosis, treatment, and management," said CEO Cho.
Write to Ji-Hyun Lee at bluesky@hankyung.com
More to Read
-
Business & PoliticsKT&G completes elementary school in Laos with employee donations
Dec 05, 2022 (Gmt+09:00)
1 Min read -
LogisticsHyundai Glovis, Malaysia’s Lion Group to enter ASEAN logistics market
Nov 16, 2022 (Gmt+09:00)
1 Min read -
ASEANKorea needs to expand investment in ASEAN, import good products more
Sep 29, 2021 (Gmt+09:00)
3 Min read
Comment 0
LOG IN